Building laboratory testing capacity
27 March 2020
Countrys: World and Kenya, Zambia, Ethiopia
The restrictions on movement imposed as a result of the COVID-19 pandemic constitute one of the largest single global challenges that the humanitarian community has ever encountered. Maintaining continuity and quality in the delivery of e...ssential assistance and services, including protection services, in the face of these restrictions requires operations to quickly innovate, leveraging fully the rich capacities and established networks within both communities of persons of concern, as well as host communities.
more
Prepared by the Independent Panel for Pandemic Preparedness and Response for the WHO Executive Board, January 2021
“The world was not as prepared as it should have been, and it must do better,” concludes a WHO panel reviewing the pandemic response "
Kenya Quality Model for Health - Level 2 Facilities
How 2016 became the worst year for Syria's children
This interim guidance is aimed at assisting organizers of international meetings attended by individuals from EVD-affected countries and individuals with a travel history to EVD-affected countries within the previous 3 weeks.
The first part is intended for organizers of international meetings, to ...safely plan and conduct these events. The second part is addressed to public health authorities directly involved in supporting such international meetings.
more
Strategy for Increasing the use of Modern Contraceptives in Nigeria
The guide explains how vaccines work and answers your common questions as well as providing up-to-date information on the current approved COVID-19 vaccinations in the UK.
This guide was written in January 2021 and updated in March 2021 and is accurate at the time of publishing. Information will b...e updated as it becomes available.
more
Compilation of country case studies and best practices. World Health Report (2010) Background Paper, 25
Each year since 2007, G-FINDER has provided policy-makers, donors, researchers and industry with a comprehensive analysis of global investment into research and development of new products to
prevent, diagnose, control or cure neglected diseases in low- and middle-income countries, making it the go...ld standard in tracking and reporting global funding for neglected disease R&D. This year’s report, the sixteenth overall, focuses on investments made in participants’ 2022 financial year (‘FY2022’) and, for the first time, adds comprehensive coverage of the product pipeline in each disease area.
more